The abstract is read at the publisher; the summary is JClub's.
Elevated taurochenodeoxycholic acid (TCDCA) is linked to Parkinson’s disease severity in patients, and it associates with worse motor and gastrointestinal deficits in a PD mouse model.
- Why it matters: Gut dysbiosis is tied to Parkinson’s disease, but microbiota-regulated metabolites that track with disease severity and contribute to blood-brain barrier dysfunction are not well defined.
- What they did: The study measured circulating TCDCA in PD patients and tested exogenous TCDCA in a PD mouse model, then mapped mechanism to vascular smooth muscle cell TGR5 signaling and PKCα-dependent mitochondrial apoptosis.
- The result: VSMC-specific Tgr5 deletion and BSH-high Lactobacillus reuteri supplementation reduce TCDCA, improve gut and BBB integrity, and lessen inflammation and PD-like phenotypes in a BSH-dependent manner.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.